ArticleOncology letters2020

Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p

Chen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.